SO
STOK icon

STRS Ohio’s Stoke Therapeutics STOK Stock Holding History

STRS Ohio’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Hold
7,000
– – ﹤0.01% 1441
2025
Q4 		$222K Buy
7,000
+600
+9% +$18K ﹤0.01% 1477
2025
Q3 		$150K Buy
+6,400
New +$110K ﹤0.01% 1675
2025
Q1 		– Sell
-3,800
Closed -$41.9K – 2013
2024
Q4 		$41.9K Buy
3,800
+1,500
+65% +$18.4K ﹤0.01% 1747
2024
Q3 		$28.3K Hold
2,300
– – ﹤0.01% 1871
2024
Q2 		$31.1K Buy
+2,300
New +$31.1K ﹤0.01% 1846
2022
Q2 		– Sell
-3,500
Closed -$73K – 2276
2022
Q1 		$73K Hold
3,500
– – ﹤0.01% 1899
2021
Q4 		$83K Hold
3,500
– – ﹤0.01% 1934
2021
Q3 		$89K Hold
3,500
– – ﹤0.01% 1967
2021
Q2 		$117K Buy
3,500
+300
+9% +$10.6K ﹤0.01% 1942
2021
Q1 		$124K Buy
3,200
+3,100
+3,100% +$176K ﹤0.01% 1905
2020
Q4 		$6K Hold
100
– – ﹤0.01% 2125
2020
Q3 		$3K Sell
100
-2,300
-96% -$65.7K ﹤0.01% 2167
2020
Q2 		$57K Hold
2,400
– – ﹤0.01% 1889
2020
Q1 		$54K Hold
2,400
– – ﹤0.01% 1774
2019
Q4 		$67K Hold
2,400
– – ﹤0.01% 1847
2019
Q3 		$51K Buy
+2,400
New +$66.9K ﹤0.01% 1877

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

STRS Ohio's STOK Position: Q1 2026 in Review

STRS Ohio held its Stoke Therapeutics (STOK) position steady in Q1 2026 at 7,000 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #1441.

STRS Ohio first reported a position in STOK in Q3 2019 and has held it in 17 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • STRS Ohio held 7,000 shares of Stoke Therapeutics worth $228K as of Q1 2026.
  • STRS Ohio left its Stoke Therapeutics share count unchanged in Q1 2026.
  • Stoke Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1441 holding.
  • STRS Ohio first reported a position in Stoke Therapeutics in Q3 2019 and has held it in 17 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.